# Oesophageal safety of high and very high power short duration pulmonary vein isolation: a randomized comparison of the 50 W and 90 W power settings—the HPSD oesophagus study

**Authors:** Ferenc Komlósi, Klaudia Vivien Nagy, Péter Perge, Zoltán Salló, István Osztheimer, Edit Tanai, Patrik Tóth, Gábor Orbán, Arnold-Béla Ferencz, Márton Boga, István Hizoh, Veronika Papp, István Hritz, Attila Szijártó, Melinda Boussoussou, Béla Merkely, László Gellér, Nándor Szegedi

PMC · DOI: 10.1093/ehjopen/oeag041 · 2026-02-25

## TL;DR

This study compares the safety of high and very high power settings for a heart procedure, finding similar risks for esophageal injury.

## Contribution

The study provides the first direct comparison of thermal safety between 50 W and 90 W power settings for pulmonary vein isolation.

## Key findings

- The 90 W (vHPSD) setting was non-inferior to 50 W (HPSD) in terms of esophageal safety.
- A smaller inter-lesion distance on the posterior wall was associated with increased risk of esophageal injury.

## Abstract

Point-by-point radiofrequency catheter ablation is commonly used for pulmonary vein isolation (PVI) in atrial fibrillation (AF). Very high power short duration (vHPSD) technology offers similar efficacy to high power short duration (HPSD) with reduced procedure times. A major complication of thermal ablation is atrio-oesophageal fistula (AEF), with oesophageal lesions and gastroparesis indicating increased risk. A direct comparison of HPSD and vHPSD regarding thermal safety is lacking. This randomized, single-centre study aimed to compare the thermal safety of vHPSD to HPSD and identify anatomical and biophysical predictors of thermal injury (ClinicalTrials.gov ID: NCT06617442).

Patients undergoing first-time PVI for AF were randomized to either HPSD (50 W) or vHPSD (90 W). The study followed a non-inferiority design, with the primary endpoint being a composite of oesophageal mucosal lesion and gastroparesis, assessed via endoscopy within 15 days post-procedure. Pre-procedural computed tomography scans were analysed for anatomical risk factors. Among 100 patients (50 per group), the primary endpoint occurred in 7 (14%) of the vHPSD group and 6 (12%) of the HPSD group (estimated mean difference −2%, lower bound of one-sided 95% CI −0.13), confirming non-inferiority. A smaller inter-lesion distance on the posterior wall was associated with increased risk (3.76 mm vs. 4.16 mm, P = 0.042).

Pulmonary vein isolation using 90 W (vHPSD) applications was non-inferior to the 50 W (HPSD) power setting in terms of oesophageal safety. A smaller inter-lesion distance on the posterior wall was predictive of oesophageal injury.

Graphical AbstractFor image description, please refer to the figure legend and surrounding text.

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), gastroparesis (MONDO:0006769)

## Full-text entities

- **Diseases:** oesophageal injury (MESH:D000077277), thermal injury (MESH:D020886), oesophageal mucosal lesion (MESH:D009059), AEF (MESH:C535326), AF (MESH:D001281), gastroparesis (MESH:D018589)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13033446/full.md

---
Source: https://tomesphere.com/paper/PMC13033446